Beta
31549

IMMUNOHISTOCHEMICAL EXPRESSION OF CATHEPSIN K IN EPIDERMAL TUMORS.

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

Background Cathepsins are a class of proteases that can degrade
components of the extracellular matrix. Their role in tumor progression and
invasion is well documented. Cathepsin K is a member of this family with
strong collagenolytic and elastolytic activity.
Objectives To assess and compare the expression of cathepsin k protease in
benign (seborrheic keratosis SK), premalignant (actinic keratosis AK),
locally malignant (basal cell carcinoma BCC) and invasive cutaneous
tumors (squamous cell carcinoma SCC).
Patients and methods The study included 45 participants divided into five
groups: one control group (9 normal skin specimens) and four case groups
(9 patients with SK, 9 patients with AK, 9 patients with BCC and 9 patients
with SCC). All skin biopsies were subjected to immunohistochemical stain
of cathespin K.
Results The epithelial and stromal scores of cathepsin K were significantly
higher in all epidermal tumors compared to the control group. Cathepsin K
expression was noticed in the benign and premalignant tumors; however it
was significantly lower than the invasive ones.
Conclusion Cathepsin K has a significant role in epidermal tumor invasion
and increased expression is correlated with more aggressive tumors.
Cathepsin K inhibitors can be a promising line of treatment of cutaneous
tumors.

DOI

10.21608/zumj.2018.31549

Keywords

cathepsin K, skin, Tumors

Volume

24

Article Issue

7

Related Issue

5376

Issue Date

2018-12-01

Receive Date

2018-12-12

Publish Date

2018-12-01

Page Start

35

Page End

45

Print ISSN

1110-1431

Online ISSN

2357-0717

Link

https://zumj.journals.ekb.eg/article_31549.html

Detail API

https://zumj.journals.ekb.eg/service?article_code=31549

Order

4

Type

Original Article

Type Code

273

Publication Type

Journal

Publication Title

Zagazig University Medical Journal

Publication Link

https://zumj.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023